Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Jenna Burton to Dog Diseases

This is a "connection" page, showing publications Jenna Burton has written about Dog Diseases.

 
Connection Strength
 
 
 
6.553
 
  1. Burton JH, Vail DM, Willcox JL, Al-Nadaf S, Adrianowycz S, Biggs D, Hayim R, Magee K, McMahon R, Mok I, Picone AM, Ralston J, Smith BM, Uyehara R, Willis AL, Johnston SA, Thamm DH. Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs. J Am Vet Med Assoc. 2025 04 01; 263(4):492-498.
    View in: PubMed
    Score: 0.755
  2. Burton JH, Johnston SA, Vail DM, Eickhoff JC, Sykes KF, Brown JR, Shen L, Gervassi A, Page RL, Willcox JL, Al-Nadaf S, Willis AL, Biggs D, Ralston J, Mok I, Kurzman ID, Huelsmeyer MK, Hayim R, Smith BM, Thamm DH. Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs. Vet Immunol Immunopathol. 2024 Jan; 267:110691.
    View in: PubMed
    Score: 0.705
  3. Culp WTN, Johnson EG, Giuffrida MA, Palm CA, Mayhew PD, Kent MS, Rebhun RB, Burton JH. Use of transrectal ultrasonography for assessment of the size and location of prostatic carcinoma in dogs. Am J Vet Res. 2019 Nov; 80(11):1012-1019.
    View in: PubMed
    Score: 0.532
  4. Al-Nadaf S, Rebhun RB, Curran KM, Venable RO, Skorupski KA, Willcox JL, Burton JH. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma. BMC Vet Res. 2018 Nov 20; 14(1):356.
    View in: PubMed
    Score: 0.498
  5. Burton JH, Venable RO, Vail DM, Williams LE, Clifford CA, Axiak-Bechtel SM, Avery AC, Thamm DH. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs. J Vet Intern Med. 2015 Jul-Aug; 29(4):1098-104.
    View in: PubMed
    Score: 0.393
  6. Burton J, Khanna C. The role of clinical trials in veterinary oncology. Vet Clin North Am Small Anim Pract. 2014 Sep; 44(5):977-87.
    View in: PubMed
    Score: 0.372
  7. Burton JH, Powers BE, Biller BJ. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011. Vet Comp Oncol. 2014 Sep; 12(3):198-204.
    View in: PubMed
    Score: 0.323
  8. Burton JH, Garrett-Mayer E, Thamm DH. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma. Vet Comp Oncol. 2013 Dec; 11(4):306-15.
    View in: PubMed
    Score: 0.316
  9. Burton JH, Mitchell L, Thamm DH, Dow SW, Biller BJ. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. J Vet Intern Med. 2011 Jul-Aug; 25(4):920-6.
    View in: PubMed
    Score: 0.299
  10. Rebhun RB, Cruz SM, York D, Mazcko CN, Razmara AM, Patkar S, Judge SJ, Sholevar CJ, Shah RK, Zamora AE, Al-Nadaf S, Vail DM, Fan TM, Burton JH, Luker ME, Skorupski KA, Lejeune AT, Woolard K, Stewart SL, Sparger EE, Young J, Cohen-Davidyan T, Huang E, Beck JA, Murphy WJ, Kent MS, Culp WTN, LeBlanc AK, Canter RJ. Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma. Front Immunol. 2025; 16:1672790.
    View in: PubMed
    Score: 0.201
  11. Mason NJ, Selmic L, Ruple A, London CA, Barber L, Weishaar K, Perry JA, Mahoney J, Flesner B, Bryan JN, Willcox JL, Burton JH, Vail DM, Kisseberth WC, Balkman CE, McCleary-Wheeler AL, Curran KM, Leeper H, Woods JP, Mutsaers AJ, Higginbotham ML, Wouda RM, Wilson-Robles H, Dervisis N, Saba C, MacDonald-Dickinson VS, Hess PR, Cherukuri A, Rotolo A, Beck JA, Patkar S, Mazcko C, LeBlanc AK. Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2. Mol Ther. 2025 04 02; 33(4):1674-1686.
    View in: PubMed
    Score: 0.192
  12. Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma. J Vet Intern Med. 2024 Jul-Aug; 38(4):2282-2292.
    View in: PubMed
    Score: 0.184
  13. Burge R, Woolard KD, Willcox JL, Rebhun RB, Burton JH, Al-Nadaf S, Skorupski KA. High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy. J Am Anim Hosp Assoc. 2023 Jul 01; 59(4):167-176.
    View in: PubMed
    Score: 0.171
  14. Yang NS, Johnson EG, Palm CA, Burton JH, Rebhun RB, Kent MS, Culp WTN. MRI characteristics of canine prostatic neoplasia. Vet Radiol Ultrasound. 2023 Jan; 64(1):105-112.
    View in: PubMed
    Score: 0.162
  15. Brady RV, Rebhun RB, Skorupski KA, Burton JH, Al-Nadaf S, Choi E, Willcox JL. Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs. J Vet Diagn Invest. 2022 May; 34(3):465-473.
    View in: PubMed
    Score: 0.157
  16. Culp WTN, Johnson EG, Giuffrida MA, Palm CA, Skorupski KA, Burton JH, Rebhun RB, Willcox JL, Kent MS, Rodriguez CO, Glaiberman CB. Procedural description and prospective evaluation of short-term outcome for the use of prostatic artery embolization in dogs with carcinoma of the prostate. J Am Vet Med Assoc. 2021 11 15; 259(10):1154-1162.
    View in: PubMed
    Score: 0.153
  17. Culp WTN, Johnson EG, Palm CA, Burton JH, Rebhun RB, Rodriguez CO, Kent MS, Glaiberman CB. Use of percutaneous microwave ablation in the treatment of retroperitoneal neoplasia in three dogs. J Am Vet Med Assoc. 2021 11 15; 259(10):1171-1177.
    View in: PubMed
    Score: 0.153
  18. LeBlanc AK, Mazcko CN, Cherukuri A, Berger EP, Kisseberth WC, Brown ME, Lana SE, Weishaar K, Flesner BK, Bryan JN, Vail DM, Burton JH, Willcox JL, Mutsaers AJ, Woods JP, Northrup NC, Saba C, Curran KM, Leeper H, Wilson-Robles H, Wustefeld-Janssens BG, Lindley S, Smith AN, Dervisis N, Klahn S, Higginbotham ML, Wouda RM, Krick E, Mahoney JA, London CA, Barber LG, Balkman CE, McCleary-Wheeler AL, Suter SE, Martin O, Borgatti A, Burgess K, Childress MO, Fidel JL, Allstadt SD, Gustafson DL, Selmic LE, Khanna C, Fan TM. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs. Clin Cancer Res. 2021 06 01; 27(11):3005-3016.
    View in: PubMed
    Score: 0.146
  19. LeBlanc AK, Atherton M, Bentley RT, Boudreau CE, Burton JH, Curran KM, Dow S, Giuffrida MA, Kellihan HB, Mason NJ, Oblak M, Selmic LE, Selting KA, Singh A, Tjostheim S, Vail DM, Weishaar KM, Berger EP, Rossmeisl JH, Mazcko C. Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats. Vet Comp Oncol. 2021 Jun; 19(2):311-352.
    View in: PubMed
    Score: 0.145
  20. Willcox JL, Spriet M, Zwingenberger AL, Phillips KL, Burton JH, Skorupski KA, Hansen KS, Affolter VK, Woolard KD, Beylin D, Giuffrida MA. Evaluation of accuracy for 18 F-FDG positron emission tomography and computed tomography for detection of lymph node metastasis in canine oral malignant melanoma. Vet Comp Oncol. 2021 Sep; 19(3):463-472.
    View in: PubMed
    Score: 0.141
  21. Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma. Vet Comp Oncol. 2019 Sep; 17(3):242-252.
    View in: PubMed
    Score: 0.128
  22. Withers SS, York D, Johnson E, Al-Nadaf S, Skorupski KA, Rodriguez CO, Burton JH, Guerrero T, Sein K, Wittenburg L, Rebhun RB. In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers. Vet Comp Oncol. 2018 Dec; 16(4):571-579.
    View in: PubMed
    Score: 0.122
  23. Halsey CHC, Thamm DH, Weishaar KM, Burton JH, Charles JB, Gustafson DL, Avery AC, Ehrhart EJ. Expression of Phosphorylated KIT in Canine Mast Cell Tumor. Vet Pathol. 2017 05; 54(3):387-394.
    View in: PubMed
    Score: 0.110
  24. Curran KM, Schaffer PA, Frank CB, Lana SE, Hamil LE, Burton JH, Labadie J, Ehrhart EJ, Avery PR. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy. Vet Comp Oncol. 2017 Dec; 15(4):1269-1279.
    View in: PubMed
    Score: 0.106
  25. Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014 Mar-Apr; 28(2):554-63.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)